MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,795,929 | -20.3% | 3,079,593 | -0.9% | 0.03% | -14.3% |
| Q2 2023 | $38,631,974 | -14.9% | 3,107,963 | -4.1% | 0.04% | -18.6% |
| Q1 2023 | $45,394,678 | -0.8% | 3,240,163 | +1.3% | 0.04% | -4.4% |
| Q4 2022 | $45,764,968 | -39.8% | 3,198,111 | +7.5% | 0.04% | -41.6% |
| Q3 2022 | $75,971,000 | -1.2% | 2,975,735 | +9.9% | 0.08% | +6.9% |
| Q2 2022 | $76,931,000 | -10.3% | 2,707,875 | +11.4% | 0.07% | +12.5% |
| Q1 2022 | $85,728,000 | -23.2% | 2,430,615 | -8.8% | 0.06% | -15.8% |
| Q4 2021 | $111,693,000 | -14.3% | 2,665,697 | +0.4% | 0.08% | -18.3% |
| Q3 2021 | $130,284,000 | +20.1% | 2,654,526 | +2.1% | 0.09% | +24.0% |
| Q2 2021 | $108,462,000 | +95.9% | 2,599,129 | +67.3% | 0.08% | +82.9% |
| Q1 2021 | $55,376,000 | +63.8% | 1,553,747 | +28.9% | 0.04% | +57.7% |
| Q4 2020 | $33,807,000 | – | 1,205,255 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |